TLGT News and Press, Teligent Inc. From 08/19/20

Teligent, Inc. (TLGT) Q2 2020 Earnings Conference Call August 19, 2020 08:00 AM ET Company Participants Tim Sawyer - President & Chief Executive Officer Damian Finio - Chief Financial Officer Conference Call Participants Presentation Operator Ladies and gentlemen,...

Penny Stock News Has Triggered Big Momentum With These Small-Caps What’s one thing you look for when trading penny stocks ? Some will say “momentum” and others will say “a catalyst”. No matter what, one usually follows the other. Specifically, news catalysts...

Teligent ( TLGT ) Q2 results : More news on: Teligent, Inc., Healthcare stocks news, Earnings news and commentary, , Stocks on the move, , Read more ...

Momenta Pharmaceuticals (NASDAQ: MNTA ) +69%  on J&J acquisition . More news on: Momenta Pharmaceuticals, Inc., Hudson Ltd., LightInTheBox Holding Co., Ltd., Stocks on the move, , Read more ...

Teligent (NASDAQ: TLGT ) : Q2 Non-GAAP EPS of -$1.54 beats by $0.16 ; GAAP EPS of -$2.56 misses by $0.36 . More news on: Teligent, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, , Read more ...

BUENA, N.J., Aug. 19, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2020. Financial Highlights Second Quarter 2020 vs. First Quarter 2020...

BUENA, N.J., Aug. 14, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, announced they will hold a conference call at 8:00AM ET on Wednesday August 19 th , 2020 to discuss the 2 nd quarter 2020 financial results and busines...

BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced the closing of the issuance of $13.8 million aggregate principal amount of...

BUENA, N.J., July 20, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (Nasdaq: TLGT) (“Teligent” or the “Company”), a New Jersey based specialty generic pharmaceutical company, is pleased to announce that John Celentano, a current independent director of Teligent, has be...

BUENA, N.J., June 22, 2020 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (“Teligent” or the “Company”), a New Jersey-based specialty generic pharmaceutical company, announced today that it received notice from The NASDAQ Stock Market LLC (“NASDAQȁ...